Published in Palliat Med on December 01, 2006
Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol (2008) 5.61
Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol (2011) 2.31
The effect on survival of continuing chemotherapy to near death. BMC Palliat Care (2011) 1.66
Quality of end-of-life cancer care in Canada: a retrospective four-province study using administrative health care data. Curr Oncol (2015) 1.44
A population-based study of age inequalities in access to palliative care among cancer patients. Med Care (2008) 1.35
Toward population-based indicators of quality end-of-life care: testing stakeholder agreement. Cancer (2008) 1.14
The coordination of primary and oncology specialty care at the end of life. J Natl Cancer Inst Monogr (2010) 1.01
Variation in medication use in cancer patients at the end of life: a cross-sectional analysis. Support Care Cancer (2012) 0.99
Impact of aggressive management and palliative care on cancer costs in the final month of life. Cancer (2015) 0.96
Quality measures for palliative care in patients with cancer: a systematic review. J Oncol Pract (2014) 0.94
Factors Associated with End-of-Life Health Service Use in Patients Dying of Cancer. Healthc Policy (2010) 0.93
Quality of end-of-life treatment for cancer patients in general wards and the palliative care unit at a regional cancer center in Japan: a retrospective chart review. Support Care Cancer (2007) 0.93
End-of-life care for persons with advanced chronic obstructive pulmonary disease: report of a national interdisciplinary consensus meeting. Can Respir J (2009) 0.90
Development of a set of process and structure indicators for palliative care: the Europall project. BMC Health Serv Res (2012) 0.87
Inequalities in end-of-life care for colorectal cancer patients in Nova Scotia, Canada. J Palliat Care (2012) 0.86
Towards a standardized method of developing quality indicators for palliative care: protocol of the Quality indicators for Palliative Care (Q-PAC) study. BMC Palliat Care (2013) 0.83
Quantifying limitations in chemotherapy data in administrative health databases: implications for measuring the quality of colorectal cancer care. Healthc Policy (2011) 0.81
Co-morbidities of persons dying of Parkinson's disease. Prog Palliat Care (2013) 0.77
The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in Taiwan. PLoS One (2015) 0.76
Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09). BMC Cancer (2014) 0.76
Use of opioid analgesics among older persons with colorectal cancer in two health districts with palliative care programs. J Pain Symptom Manage (2012) 0.75
Access to oncology consultation in a cancer cohort in northeastern Ontario. Curr Oncol (2015) 0.75
Dying among older adults in Switzerland: who dies in hospital, who dies in a nursing home? BMC Palliat Care (2016) 0.75
Effect of hospice care on quality indicators of end-of-life care among patients with liver cancer: a national longitudinal population-based study in Taiwan 2000-2011. BMC Palliat Care (2015) 0.75
Using linked administrative and disease-specific databases to study end-of-life care on a population level. BMC Palliat Care (2016) 0.75
A retrospective analysis of factors associated with selection of end-of-life care and actual place of death for patients with cancer. BMJ Open (2014) 0.75
Association of code status discussion with invasive procedures among advanced-stage cancer and noncancer patients. Int J Gen Med (2017) 0.75
Predictors of high healthcare costs in elderly patients with liver cancer in end-of-life: a longitudinal population-based study. BMC Cancer (2017) 0.75
Assessing quality using administrative data. Ann Intern Med (1997) 8.29
Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol (2004) 7.45
The intraclass correlation coefficient as a measure of reliability. Psychol Rep (1966) 7.27
Part 1: Quality of care--what is it? N Engl J Med (1996) 6.72
Quality of health care. Part 2: measuring quality of care. N Engl J Med (1996) 6.46
Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA (2004) 5.43
Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol (2003) 4.50
Research methods used in developing and applying quality indicators in primary care. BMJ (2003) 3.83
Geographic access to health care for rural Medicare beneficiaries. J Rural Health (2006) 3.04
Quality of care: 1. What is quality and how can it be measured? Health Services Research Group. CMAJ (1992) 2.66
Identification in administrative databases of women dying of breast cancer. J Clin Oncol (2006) 2.47
Family physician continuity of care and emergency department use in end-of-life cancer care. Med Care (2003) 2.46
Patient-focused, family-centered end-of-life medical care: views of the guidelines and bereaved family members. J Pain Symptom Manage (2001) 2.22
Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol (2006) 1.75
The concept of quality of life of dying persons in the context of health care. J Pain Symptom Manage (1999) 1.62
Proposed agenda for the measurement of quality-of-care outcomes in oncology practice. J Clin Oncol (1999) 1.59
Quality of breast cancer care: what do we know? J Clin Oncol (2002) 1.49
The case identification challenge in measuring quality of cancer care. J Clin Oncol (2002) 1.39
Time spent in hospital in the last six months of life in patients who died of cancer in Ontario. J Clin Oncol (2002) 1.21
A new method for measuring continuity of care in family practice residencies. J Fam Pract (1987) 1.21
Developing a reliable, valid, and feasible plan for quality-of-care measurement for cancer: how should we measure? Med Care (2002) 1.14
Toward population-based indicators of quality end-of-life care: testing stakeholder agreement. Cancer (2008) 1.14
Research agenda for developing measures to examine quality of care and quality of life of patients diagnosed with life-limiting illness. J Pain Symptom Manage (1999) 1.06
Effective number of subjects and number of raters for inter-rater reliability studies. Stat Med (2006) 1.02
"The best places to die". BMJ (2003) 0.99
Home visits by family physicians during the end-of-life: Does patient income or residence play a role? BMC Palliat Care (2005) 0.98
Measuring quality of care at the end of life. Arch Intern Med (1998) 0.95
The uses of provincial administrative health databases for research on palliative care: Insights from British Columbia, Canada. BMC Palliat Care (2005) 0.88
Analytic framework for clinician provision of end-of-life care. J Palliat Care (2002) 0.86
Validating quality indicators for hospital care. Jt Comm J Qual Improv (1997) 0.85
The forgotten component of the quality triad: can we still learn something from "structure"? Jt Comm J Qual Improv (2001) 0.85
End-of-life population study methods. Can J Public Health (2001) 0.83
Quality assurance in palliative care: some of the problems. Eur J Cancer Care (Engl) (1995) 0.83
Capacities and limitations of information systems as data sources on quality of care at the end of life. J Pain Symptom Manage (2001) 0.82
Selecting clinical outcome indicators for monitoring quality of care. Healthc Manage Forum (1996) 0.82
Association of colonoscopy and death from colorectal cancer. Ann Intern Med (2008) 15.51
Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med (2009) 6.46
Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol (2011) 5.67
Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology (2007) 5.30
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ (2010) 4.73
Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol (2009) 4.39
Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology (2007) 4.37
Does reimbursement influence chemotherapy treatment for cancer patients? Health Aff (Millwood) (2006) 4.33
Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. CMAJ (2004) 4.13
Impact of androgen deprivation therapy on cardiovascular disease and diabetes. J Clin Oncol (2009) 4.07
Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst (2006) 4.01
Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology (2010) 3.91
Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology (2008) 3.71
Physician factors associated with discussions about end-of-life care. Cancer (2010) 3.54
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. J Clin Oncol (2012) 3.36
How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Aff (Millwood) (2010) 3.24
Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. Clin Gastroenterol Hepatol (2009) 3.20
Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg (2003) 3.13
Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol (2008) 2.91
Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol (2008) 2.68
Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med (2008) 2.64
Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol (2010) 2.56
Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. JAMA (2012) 2.47
Family physician continuity of care and emergency department use in end-of-life cancer care. Med Care (2003) 2.46
A population-based analysis of outpatient colonoscopy in adults assisted by an anesthesiologist. Anesthesiology (2009) 2.41
Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med (2009) 2.36
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst (2006) 2.34
Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study. Ann Intern Med (2011) 2.34
Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol (2011) 2.31
Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer (2003) 2.26
Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol (2009) 2.26
The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr (2010) 2.25
The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol (2005) 2.21
Trends in the place of death of cancer patients, 1992-1997. CMAJ (2003) 2.18
High-kappa dielectrics for advanced carbon-nanotube transistors and logic gates. Nat Mater (2002) 2.18
Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology (2004) 2.17
Rates of new or missed colorectal cancer after barium enema and their risk factors: a population-based study. Am J Gastroenterol (2008) 2.14
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Measuring complications of cancer treatment using the SEER-Medicare data. Med Care (2002) 2.05
End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector. Cancer (2010) 2.01
Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med (2013) 2.00
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol (2012) 2.00
A population-based estimate of the extent of colorectal cancer screening in Ontario. Am J Gastroenterol (2004) 1.95
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med (2002) 1.90
Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology (2011) 1.86
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol (2006) 1.75
Racial and ethnic differences in end-of-life care in fee-for-service Medicare beneficiaries with advanced cancer. J Am Geriatr Soc (2008) 1.74
Colorectal cancer screening with nurse-performed flexible sigmoidoscopy: results from a Canadian community-based program. Gastrointest Endosc (2006) 1.72
Breast cancer survivors' perceptions of survivorship care options. J Clin Oncol (2011) 1.72
Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol (2008) 1.70
The effect on survival of continuing chemotherapy to near death. BMC Palliat Care (2011) 1.66
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer. J Clin Oncol (2006) 1.64
Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology (2013) 1.63
Hospital characteristics, clinical severity, and outcomes for surgical oncology patients. Surgery (2010) 1.62
Onset and clinical course of bleeding and perforation after outpatient colonoscopy: a population-based study. Gastrointest Endosc (2010) 1.52
Validation of instruments to evaluate primary healthcare from the patient perspective: overview of the method. Healthc Policy (2011) 1.51
Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data. Value Health (2008) 1.48
Lower use of hospice by cancer patients who live in minority versus white areas. J Gen Intern Med (2007) 1.47
Behavioral health services for women who have breast cancer. J Clin Oncol (2008) 1.45
Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol (2005) 1.44
Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04. CMAJ (2007) 1.42
Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. J Clin Oncol (2003) 1.41
Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor. J Pharmacol Exp Ther (2006) 1.41
Examining the potential relationship between multidisciplinary cancer care and patient survival: an international literature review. J Surg Oncol (2010) 1.40
Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis. BMC Cancer (2009) 1.40
Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol (2006) 1.39
Advancing performance measurement in oncology: quality oncology practice initiative participation and quality outcomes. J Oncol Pract (2011) 1.38
Primary care continuity and location of death for those with cancer. J Palliat Med (2003) 1.38
Preventive care in prostate cancer patients: following diagnosis and for five-year survivors. J Cancer Surviv (2011) 1.38
Association of socioeconomic status and receipt of colorectal cancer investigations: a population-based retrospective cohort study. CMAJ (2004) 1.36
Elapsed time from breast cancer detection to first adjuvant therapy in a Canadian province, 1999-2000. CMAJ (2004) 1.36
Racial segregation and disparities in cancer stage for seniors. J Gen Intern Med (2008) 1.36
Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer. Dis Colon Rectum (2009) 1.33
Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data. Clin Gastroenterol Hepatol (2008) 1.33
Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. J Clin Oncol (2013) 1.32
How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer? Cancer (2010) 1.30
Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol (2007) 1.29
Racial segregation and disparities in breast cancer care and mortality. Cancer (2008) 1.28
Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys (2006) 1.25
What Patients Tell Us about Primary Healthcare Evaluation Instruments: Response Formats, Bad Questions and Missing Pieces. Healthc Policy (2011) 1.24
Associations among cancer survivorship discussions, patient and physician expectations, and receipt of follow-up care. J Clin Oncol (2010) 1.23
The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data. Arch Otolaryngol Head Neck Surg (2004) 1.22
Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value Health (2011) 1.22
Hospice care and survival among elderly patients with lung cancer. J Palliat Med (2011) 1.22
Methodological issues in the use of administrative claims data to study surveillance after cancer treatment. Med Care (2002) 1.21
An overview of confirmatory factor analysis and item response analysis applied to instruments to evaluate primary healthcare. Healthc Policy (2011) 1.21
Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer. J Clin Oncol (2008) 1.21
Disparities in hospice care among older women dying with ovarian cancer. Gynecol Oncol (2011) 1.20
Accessibility from the patient perspective: comparison of primary healthcare evaluation instruments. Healthc Policy (2011) 1.20
Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists. J Cancer Surviv (2013) 1.18
Geographic variation in physicians' responses to a reimbursement change. N Engl J Med (2011) 1.18
Transitions in care during the end of life: changes experienced following enrolment in a comprehensive palliative care program. BMC Palliat Care (2005) 1.17
Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer. Dig Dis Sci (2007) 1.15